Caxton Associates (New York)’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,948
Closed -$14.8M 587
2024
Q1
$14.8M Buy
+25,948
New +$14.3M 0.83% 15
2023
Q4
Sell
-18,251
Closed -$8.38M 537
2023
Q3
$8.38M Sell
18,251
-10,846
-37% -$4.85M 1.15% 23
2023
Q2
$12.7M Buy
+29,097
New +$11.7M 1.87% 7
2019
Q3
Sell
-5,097
Closed -$656K 532
2019
Q2
$656K Buy
5,097
+2,438
+92% +$293K 0.08% 143
2019
Q1
$306K Buy
+2,659
New +$264K 0.04% 242
2018
Q4
Sell
-4,813
Closed -$475K 453
2018
Q3
$475K Sell
4,813
-4,591
-49% -$438K 0.03% 240
2018
Q2
$805K Sell
9,404
-3,577
-28% -$312K 0.04% 194
2018
Q1
$1.08M Buy
+12,981
New +$1.14M 0.06% 175
2017
Q3
Sell
-7,600
Closed -$554K 609
2017
Q2
$554K Hold
7,600
0.02% 305
2017
Q1
$548K Buy
+7,600
New +$509K ﹤0.01% 228

Other funds holding SNPS

Caxton Associates (New York)'s SNPS Position: Q2 2024 in Review

Caxton Associates (New York) sold out of Synopsys (SNPS) in Q2 2024, closing a stake of 25,948 shares — an estimated $14.8M sold.

Caxton Associates (New York) first reported a position in SNPS in Q1 2017 and held it in 10 quarters. The position peaked at $14.8M in Q1 2024. 1,252 funds tracked by Wall St. Rank hold SNPS as of Q2 2024.

  • Caxton Associates (New York) reported no remaining Synopsys position as of Q2 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 25,948 Synopsys shares in Q2 2024, an estimated $14.8M.
  • Caxton Associates (New York) first reported a position in Synopsys in Q1 2017 and held it in 10 quarters.
  • Caxton Associates (New York)'s Synopsys position peaked at $14.8M in Q1 2024.
  • 1,252 funds tracked by Wall St. Rank held Synopsys as of Q2 2024.

Based on Caxton Associates (New York)'s 13F filing for Q2 2024, filed 14 Aug 2024.